Estrogen and related hormone effects

Estrogen and related steroid hormones exert their effects largely by binding to nuclear receptors—proteins that, once activated, travel to the nucleus and directly regulate which genes a cell turns on or off. In breast cancer, this signaling pathway is central: roughly two-thirds of breast tumors are driven by estrogen receptor activity, which is why drugs like tamoxifen, which blocks the receptor, and aromatase inhibitors, which reduce estrogen production, have become cornerstones of treatment. Glucocorticoids interact with overlapping receptor machinery, complicating the picture of how these hormonal signals are integrated in both healthy tissue and disease. Researchers are actively working to understand how coregulator proteins fine-tune receptor behavior, why some tumors become resistant to endocrine therapies, and whether targeting specific steps in the signaling pathway can improve outcomes for patients with hormone-driven cancers.

Works

122,401

Total citations

2,693,981

Keywords

EstrogenReceptorSignalingBreast CancerGlucocorticoidsNuclear Receptors